A. FILIA

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
An effective circulating tumour marker is needed for melanoma especially with the advent of targeted therapies. Gene expression studies examining primary melanomas have shown that increased expression of osteopontin (SPP1) is associated with poor prognosis. Studies subsequently reported higher blood levels in melanoma patients with metastatic disease than(More)
  • 1